These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 21962184)

  • 21. Spectrometric analysis of mercury content in 549 skin-lightening products: is mercury toxicity a hidden global health hazard?
    Hamann CR; Boonchai W; Wen L; Sakanashi EN; Chu CY; Hamann K; Hamann CP; Sinniah K; Hamann D
    J Am Acad Dermatol; 2014 Feb; 70(2):281-7.e3. PubMed ID: 24321702
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dermoscopic and reflectance confocal microscopic features of exogenous ochronosis.
    Gil I; Segura S; Martínez-Escala E; Lloreta J; Puig S; Vélez M; Pujol RM; Herrero-González JE
    Arch Dermatol; 2010 Sep; 146(9):1021-5. PubMed ID: 20855704
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Exogenous ochronosis in the United States.
    Lawrence N; Bligard CA; Reed R; Perret WJ
    J Am Acad Dermatol; 1988 May; 18(5 Pt 2):1207-11. PubMed ID: 3372785
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cutaneous annular sarcoidosis developing on a background of exogenous ochronosis: a report of two cases and review of the literature.
    Moche MJ; Glassman SJ; Modi D; Grayson W
    Clin Exp Dermatol; 2010 Jun; 35(4):399-402. PubMed ID: 19663829
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Patterns of Over-the-counter Lightening Agent Use among Patients with Hyperpigmentation Disorders: A United States-based Cohort Study.
    Saade DS; Maymone MBC; Secemsky EA; Kennedy KF; Vashi NA
    J Clin Aesthet Dermatol; 2018 Jul; 11(7):26-30. PubMed ID: 30057662
    [No Abstract]   [Full Text] [Related]  

  • 26. Inorganic mercury poisoning associated with skin-lightening cosmetic products.
    Chan TY
    Clin Toxicol (Phila); 2011 Dec; 49(10):886-91. PubMed ID: 22070559
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Widespread use of toxic skin lightening compounds: medical and psychosocial aspects.
    Ladizinski B; Mistry N; Kundu RV
    Dermatol Clin; 2011 Jan; 29(1):111-23. PubMed ID: 21095535
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Exogenous ochronosis.
    Nagler A; Hale CS; Meehan SA; Leger M
    Dermatol Online J; 2014 Dec; 20(12):. PubMed ID: 25526333
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Skin bleaching: highlighting the misuse of cutaneous depigmenting agents.
    Dadzie OE; Petit A
    J Eur Acad Dermatol Venereol; 2009 Jul; 23(7):741-50. PubMed ID: 19470077
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Exogenous ochronosis in a Mexican-American woman.
    Howard KL; Furner BB
    Cutis; 1990 Mar; 45(3):180-2. PubMed ID: 2311433
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Skin-lightening practice among women living in Jordan: prevalence, determinants, and user's awareness.
    Hamed SH; Tayyem R; Nimer N; Alkhatib HS
    Int J Dermatol; 2010 Apr; 49(4):414-20. PubMed ID: 20465697
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Skin lightening cream induced dermatitis and atrophy.
    Bremmer M; Gardner J; Driscoll M
    Dermatol Online J; 2011 Mar; 17(3):13. PubMed ID: 21426879
    [TBL] [Abstract][Full Text] [Related]  

  • 33. "The fairer the better?" Use of potentially toxic skin bleaching products.
    Darj E; Infanti JJ; Ahlberg BM; Okumu J
    Afr Health Sci; 2015 Dec; 15(4):1074-80. PubMed ID: 26958006
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Aesthetic problems associated with the cosmetic use of bleaching products.
    Ly F; Soko AS; Dione DA; Niang SO; Kane A; Bocoum TI; Dieng MT; Ndiaye B
    Int J Dermatol; 2007 Oct; 46 Suppl 1():15-7. PubMed ID: 17919199
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Combinations of potent topical steroids, mercury and hydroquinone are common in internationally manufactured skin-lightening products: a spectroscopic study.
    Maneli MH; Wiesner L; Tinguely C; Davids LM; Spengane Z; Smith P; van Wyk JC; Jardine A; Khumalo NP
    Clin Exp Dermatol; 2016 Mar; 41(2):196-201. PubMed ID: 26211494
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Use of skin lightening creams.
    Olumide YM
    BMJ; 2010 Nov; 341():c6102. PubMed ID: 21098586
    [No Abstract]   [Full Text] [Related]  

  • 37. Skin-Lightening Products: Consumer Preferences and Costs.
    Cheng AD; De La Garza H; Maymone MBC; Johansen VM; Vashi NA
    Cureus; 2021 Aug; 13(8):e17245. PubMed ID: 34540471
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Women's perceptions of the benefits and risks of skin-lightening creams in two South African communities.
    Dlova N; Hamed SH; Tsoka-Gwegweni J; Grobler A; Hift R
    J Cosmet Dermatol; 2014 Sep; 13(3):236-41. PubMed ID: 25196692
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Exogenous Ochronosis (EO): Skin lightening cream causing rare caviar-like lesion with banana-like pigments; review of literature and histological comparison with endogenous counterpart.
    Qorbani A; Mubasher A; Sarantopoulos GP; Nelson S; Fung MA
    Autops Case Rep; 2020 Sep; 10(4):e2020197. PubMed ID: 33344320
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Use of skin lightening creams. Some clinical pointers to use.
    Adebayo F
    BMJ; 2011 Mar; 342():d1304. PubMed ID: 21363849
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.